Resolution of Paraneoplastic Cutaneous Angioendotheliomatosis After CAR T‐Cell Therapy in TP53‐Deleted CLL: A Case Report

Feras Alfraih, Mostafa F Mohammed Saleh, David Li, Razan Mohty, Mohamed Kharfan‐Dabaja · 2026

Read Resolution of Paraneoplastic Cutaneous Angioendotheliomatosis After CAR T‐Cell Therapy in TP53‐Deleted CLL: A Case Report by Feras Alfraih, Mostafa F Mohammed Saleh, David Li, Razan Mohty, Mohamed Kharfan‐Dabaja (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13421918.txt.

Description

Alfraih and colleagues describe in this 2026 case report a skin disorder that melted away after cellular immunotherapy aimed at leukemia. Their patient was a 58-year-old man with high-risk chronic lymphocytic leukemia carrying a TP53 mutation and chromosome deletion, who developed rapidly growing, fungating skin lesions despite five earlier lines of treatment.

Biopsy showed reactive angioendotheliomatosis, a rare benign proliferation of blood vessels inside the skin, with no leukemia cells present in the lesions. Local care failed, but after CD19-directed CAR T-cell therapy with lisocabtagene maraleucel, engineered immune cells that hunt B cells, the skin lesions regressed markedly. Oddly, his leukemia still showed measurable residual disease and later relapsed systemically, requiring a transplant. The authors read the skin cure as immune modulation by the therapy, not direct killing of tumor in the skin.

Catalog record

CREATORFeras Alfraih, Mostafa F Mohammed Saleh, David Li, Razan Mohty, Mohamed Kharfan‐Dabaja
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE12 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13421918

Browse the full library · About the Tower of Babel